-
-
Call more information
660-596-2224 -
ASA Monitor October 2022, Vol. 86, 16. Which of the following agents is MOST likely to decrease intraocular pressure? □ (A) Fentanyl □ (B) Succinylcholine □ (C) Midazolam Ophthalmic surgeries are the most commonly performed surgical procedures in the United States. Intraocular pressure (IOP) is defined by the pressure exerted by different components of the globe to the containing […]
Read MoreAuthor: Amy Gallagher ASA Monitor November 2022, Vol. 86, 16. Accepting and adapting to change is a function of growth and development, which is a critical factor in the complex and fast-growing pursuit of personalized medicine. As a clinical pharmacologist, Robert L. Barkin, MBA, PharmD, FCP, OFRSM, has been involved in pain management for decades. Barkin […]
Read MoreAuthors: Richard Simoneaux; Steven L. Shafer, MD, FASA ASA Monitor October 2022, Vol. 86, 1–8. In 2012, the Nobel Prize in Chemistry was awarded to Robert J. Lefkowitz, Howard Hughes Medical Institute/Duke University Medical Center, and Brian K. Kobilka, Stanford University School of Medicine, for “groundbreaking discoveries that reveal the inner workings of… G-protein-coupled receptors” (asamonitor.pub/3Cb1vVL). G-protein-coupled […]
Read MoreAuthors: Richard P. Dutton, MD, MBA, FASA et al ASA Monitor November 2022, Vol. 86, 21–22. Most hospitals in America are seeking an increase in anesthesia services, mainly due to increasing need for nonoperating room coverage. At present, the market demand for anesthesia clinicians exceeds the available supply by a substantial margin. Among the possible solutions […]
Read MoreAuthors: Archit Sharma, MD, MBA, FASE et al ASA Monitor November 2022, Vol. 86, 31–32. Ever since the first pacemaker was implanted in 1958, the world has witnessed a consistent uptick in cardiac device therapy (Miller’s Anesthesia, 7th edition, 2009). The term cardiac implantable electronic device (CIED) refers to any permanently implantable cardiac pacemaker or any artificial implantable […]
Read MoreAuthor: Catlin Nalley ASA Monitor October 2022, Vol. 86, 1–8. It is one of the most enduring challenges faced by the specialty and one unique to anesthesiology – the discrepancy in Medicare payments for anesthesia services known as the “33% Problem”. Whereas Medicare rates for other specialties represent between 75% and 85% of their commercial payment […]
Read MoreASA Monitor October 2022, Vol. 86, 15. Your next patient is scheduled for laparoscopic abdominal hysterectomy. She recalls having a severe sore throat after her last surgery and asks if there is any way to prevent it this time. According to a recent study evaluating the use of smaller diameter tracheal tubes for the prevention of […]
Read MoreASA Monitor November 2022, Vol. 86, 11. Because of our busy OR schedule, a complex, high-risk, scheduled surgical procedure was performed during late-night hours by surgeons and anesthesiology professionals who had been at work since early in the morning. The patient entered the OR on schedule at 7 p.m., and incision was made at 8:30 p.m. […]
Read MoreAuthors: Richard Simoneaux; Steven L. Shafer, MD, FASA ASA Monitor November 2022, Vol. 86, 1–4. The monkeypox virus, like its cousin the variola virus (the causative agent of smallpox), is a DNA virus of the genus Orthopoxvirus. Monkeypox was first noted in the late 1950s when outbreaks of a “pox-like disease” were observed in monkeys housed […]
Read MoreAmerican Society of Anesthesiologists (ASA) The American Society of Anesthesiologists calls on Congress to block a nearly 4.5% Medicare payment cut to anesthesiologists and other physicians included in the Centers for Medicare & Medicaid Services (CMS) 2023 Medicare Physician Fee Schedule (PFS) final rule released this week. These significant cuts will compound the financial strain anesthesia groups are already […]
Read More